Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
45.42
-0.29 (-0.63%)
At close: Oct 5, 2026, 4:00 PM EDT
45.66
+0.23 (0.52%)
After-hours: Oct 5, 2026, 7:30 PM EDT
Spruce Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
130.54M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.91M | -5.18M | -51.32% |
| Dec 31, 2023 | 10.09M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Atrium Therapeutics | 35.84M |
| Seer, Inc. | 14.22M |
| Innate Pharma | 11.21M |
| Caribou Biosciences | 10.04M |
| Armata Pharmaceuticals | 5.54M |
| Cibus | 4.35M |
| NRx Pharmaceuticals | 3.39M |
| Kazia Therapeutics | 1.27M |
SPRB News
- 18 days ago - Spruce Biosciences management to meet virtually with B. Riley - TheFly
- 18 days ago - Spruce Biosciences initiated with a Buy at Lake Street on Sanfilippo asset - TheFly
- 18 days ago - Spruce Biosciences initiated with a Buy at Lake Street - TheFly
- 19 days ago - Spruce Biosciences management to meet virtually with Craig-Hallum - TheFly
- 20 days ago - Spruce Biosciences Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 27 days ago - Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 5 weeks ago - Spruce Biosciences announces launch of MPS3BStudy.com - TheFly
- 5 weeks ago - Spruce Biosciences Announces Launch of MPS3BStudy.com - Business Wire